139 related articles for article (PubMed ID: 3155614)
1. Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities.
Fernandes DJ; Cranford SK
Biochem Pharmacol; 1985 Jan; 34(1):125-32. PubMed ID: 3155614
[TBL] [Abstract][Full Text] [Related]
2. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
Grem JL; Fischer PH
Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
[TBL] [Abstract][Full Text] [Related]
3. Human leukemic cells resistant to 5-fluoro-2'-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides.
Bapat AR; Zarow C; Danenberg PV
J Biol Chem; 1983 Apr; 258(7):4130-6. PubMed ID: 6220000
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid.
Fernandes DJ; Cranford SK
Cancer Res; 1986 Apr; 46(4 Pt 1):1741-7. PubMed ID: 2936450
[TBL] [Abstract][Full Text] [Related]
6. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
7. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
Sobrero AF; Moir RD; Bertino JR; Handschumacher RE
Cancer Res; 1985 Jul; 45(7):3155-60. PubMed ID: 3159474
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
Chemioterapia; 1985 Dec; 4(6):454-9. PubMed ID: 2937563
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Mini E; Moroson BA; Bertino JR
Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
[TBL] [Abstract][Full Text] [Related]
10. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
Davis ST; Berger SH
Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
[TBL] [Abstract][Full Text] [Related]
11. A method for the determination of total, free, and 5-fluorodeoxyuridylate-bound thymidylate synthase in cell extracts.
Fernandes DJ; Cranford SK
Anal Biochem; 1984 Nov; 142(2):378-85. PubMed ID: 6241433
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, dUMP and TMP in cultured cell models by LC-MS/MS.
Carli D; Honorat M; Cohen S; Megherbi M; Vignal B; Dumontet C; Payen L; Guitton J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2937-44. PubMed ID: 19620028
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P; Bertino JR
Biochem Pharmacol; 1987 Sep; 36(18):2905-11. PubMed ID: 2958010
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the activation of fluorodeoxyuridine by substrate competition and feedback inhibition in 647V cells.
Vazquez-Padua MA; Risueno C; Fischer PH
Cancer Res; 1989 Feb; 49(3):618-24. PubMed ID: 2521299
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of resistance to fluoropyrimidines.
Zhang ZG; Harstrick A; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
[TBL] [Abstract][Full Text] [Related]
16. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
Roobol C; De Dobbeleer GB; Bernheim JL
Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of a naturally occurring amino acid substitution in human thymidylate synthase.
Hughey CT; Barbour KW; Berger FG; Berger SH
Mol Pharmacol; 1993 Aug; 44(2):316-23. PubMed ID: 8355668
[TBL] [Abstract][Full Text] [Related]
18. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
19. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
Washtien WL; Santi DV
Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
Ingraham HA; Tseng BY; Goulian M
Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
